The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Antidepressant Discontinuation Syndrome

Cluster of symptoms emerging after abrupt cessation or rapid tapering of antidepressants.

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Psikiyatri department. Book Appointment →

What is Antidepressant Discontinuation Syndrome?

Antidepressant discontinuation syndrome occurs in 20-50% of patients who abruptly stop or rapidly taper antidepressants taken for at least 4-6 weeks. It is most commonly described with selective serotonin reuptake inhibitors (especially paroxetine) and serotonin-norepinephrine reuptake inhibitors (especially venlafaxine and duloxetine). Symptoms typically emerge within 2-4 days of discontinuation and resolve over 1-2 weeks.

Pathophysiology involves transient downregulation of receptors and dysregulation of serotonergic and noradrenergic transmission after sudden removal of the medication. Risk increases with longer duration of treatment, higher doses, shorter half-life, and patient-specific pharmacogenetic variation. The mnemonic FINISH summarizes characteristic features: Flu-like symptoms, Insomnia, Nausea, Imbalance, Sensory disturbances (electric shock-like sensations), and Hyperarousal.

Differentiating discontinuation symptoms from depressive relapse is essential — the former resolves with reinstatement within 24-72 hours, whereas relapse evolves more gradually. Prevention rests on slow taper schedules (often over weeks to months for high-risk drugs), patient education, and switching to fluoxetine prior to taper when feasible. Severe or persistent cases may benefit from a hyperbolic taper using compounded or liquid formulations.

Symptoms

Flu-like symptoms (myalgia, malaise, headache, sweating)
Insomnia and vivid dreams
Nausea, vomiting, diarrhea
Imbalance, dizziness, vertigo
Sensory disturbances ("brain zaps", paresthesias)
Hyperarousal: anxiety, irritability, agitation
Mood changes, dysphoria, depressive features
Cognitive symptoms: difficulty concentrating, derealization

Risk Factors

Use of short half-life antidepressants (paroxetine, venlafaxine, duloxetine)
Long duration of treatment (>6-8 weeks)
High doses or rapid tapering
Prior history of discontinuation symptoms
Concurrent CYP2D6 inhibitors
Pharmacogenetic variations in drug metabolism
Anxious or somatically focused patients
Lack of patient education about safe discontinuation

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Distressing symptoms appearing within days of dose reduction
  • Symptoms not relieved by simple supportive measures
  • Concerns about discontinuation versus relapse
  • Severe or worsening sensory disturbances
  • Suicidality or major mood symptoms after discontinuation
  • Need for prescription review and tapering plan

Treatment Methods

01
Reinstate previous dose, then taper slowly (often hyperbolic schedule)
02
Switch to fluoxetine before tapering for short half-life agents
03
Patient education about timing and self-monitoring
04
Symptomatic management: antiemetics, analgesics, sleep hygiene
05
Cognitive behavioral support and reassurance
06
Address underlying mood disorder relapse if present
07
Pharmacogenetic testing in difficult cases
08
Compounded or liquid formulations for ultra-slow taper

Which Department to Visit?

You can visit our Psikiyatri department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Psikiyatri Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Generalized Anxiety Disorder (GAD)

Psikiyatri

Generalized anxiety disorder is characterized by excessive, difficult-to-control worry most days for at least six months, accompanied by physical symptoms such as muscle tension, fatigue, and sleep disturbance that impair daily functioning.

Psychiatric Insomnia and Sleep Disorders

Psikiyatri

Effects of depression, anxiety and other psychiatric disorders on sleep and their treatment.

Depression

Psikiyatri

What is depression, how does it differ from sadness, and how is it treated?

Anxiety Disorder

Psikiyatri

What is anxiety disorder, how does it differ from normal worry, and how is it overcome?

Panic Attack

Psikiyatri

What is a panic attack, how is this condition — often confused with a heart attack — managed and prevented?

OCD (Obsessive Compulsive Disorder)

Psikiyatri

What is OCD, how are intrusive thoughts and compulsive behaviors treated?

PTSD (Post-Traumatic Stress Disorder)

Psikiyatri

What is PTSD, how are flashbacks and hyperarousal after trauma treated?

Bipolar Disorder

Psikiyatri

Bipolar disorder is a chronic mood disorder characterized by episodes of mania or hypomania alternating with depressive episodes; accurate diagnosis and long-term treatment with mood stabilizers are essential to reduce relapses and improve functioning.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.